Shared Decision Making: Understanding Your Immunotherapy Choices

A webinar held by the KidneyCan a patient-created and patient-driven movement, drawing energy and motivation from people all over the United States and the world whose lives are impacted by kidney cancer.

A panel of expert oncologists including Dr. Naomi Haas from Penn Medicine, Dr. Hans Hammers from UTSW, and Dr. Monty Pal from City of Hope discuss how they share the immunotherapy treatment decision-making process with their patients.

How do these experts take your health, your kidney cancer subtype, and your preferences into account when they suggest options for your immunotherapy treatments?

The panel will also share new immunotherapy treatments now being offered in clinical trials.

Note: the expert panel are oncologist from the United States. They may refer to treatments that are not approved in Canada.

Kidney Cancer Canada